Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma
- Resource Type
- Article
- Source
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p4672-4672, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020